SPIRIT III Clinical Trial of the XIENCE™ V Everolimus Eluting Coronary Stent System (EECSS)

This study is ongoing, but not recruiting participants.
Information provided by Abbott Vascular

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Stents
			Coronary Artery Disease
			Total Coronary Occlusion
			Coronary Artery Restenosis
			Stent Thrombosis
			Vascular Disease
			Myocardial Ischemia
			Coronary Artery Stenosis
2		Additional conditions recognized in this trial
			Coronary Occlusion
			Coronary Restenosis
			Coronary Stenosis
			Ischemia
			Thrombosis
			Vascular Diseases
3		More general conditions related to this trial
			Arterial Occlusive Diseases
			Arteriosclerosis
			Cardiovascular Diseases
			Coronary Disease
			Embolism and Thrombosis
			Heart Diseases
			Pathologic Processes
4		Additional drug interventions recognized in this trial
			Everolimus
			Paclitaxel
5		More general drug interventions related to this trial
			Antimitotic Agents
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Immunologic Factors
			Immunosuppressive Agents
			Mitosis Modulators
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
			Tubulin Modulators
6		Sponsors listed in this trial
			Abbott Vascular